 |
市場調査レポート
商品コード
1373885
遺伝子編集の世界市場の規模、シェア、成長分析：タイプ別、用途別 - 産業予測（2023年～2030年）Global Gene Editing Market Size, Share, Growth Analysis, By Type(CRISPR/Cas9, TALENS), By Application(Diagnostics, Drug discovery and development) - Industry Forecast 2023-2030 |
||||||
| 遺伝子編集の世界市場の規模、シェア、成長分析：タイプ別、用途別 - 産業予測（2023年～2030年） |
|
出版日: 2023年10月16日
発行: SkyQuest
ページ情報: 英文 157 Pages
納期: 3～5営業日
|
- 全表示
- 概要
- 目次
世界の遺伝子編集の市場規模は、2021年に38億米ドルとなり、2022年の40億6,000万米ドルから2030年までに68億7,000万米ドルに達し、予測期間（2023年～2030年）にCAGRで6.8%の成長が見込まれています。
市場は近年大幅な成長と進歩を遂げ、バイオテクノロジーと遺伝子研究の部門に革命をもたらしています。市場は、個別化医療に対する需要の高まり、遺伝子工学の進歩、研究開発活動への投資の増加によって牽引されています。遺伝子疾患の治療、がん免疫療法、感染症など、遺伝子編集の治療応用は絶大な注目を集めており、市場成長を後押ししています。さらに、農業部門では、収穫高、栄養価、病害虫耐性を向上させた作物を開発するために遺伝子編集技術の採用が急増しています。世界市場は、製薬企業、バイオテクノロジー企業、研究機関を含む主要企業の激しい競争が特徴です。これらの企業は、研究能力を強化し製品ポートフォリオを拡大するために、戦略的パートナーシップ、M&A、提携に積極的に取り組んでいます。北米は、先進の医療インフラの存在、強力な研究基盤、ゲノム研究への多額の投資により、世界市場を独占しています。しかし、精密医療への注目の高まり、医療費の増加、中国、日本、インドなどの国々における政府の積極的な取り組みなどにより、アジア太平洋が大きな成長を示すと予測されます。この市場は政府の支援的な取り組みや、学術機関とバイオテクノロジー企業との提携、遺伝子編集分野に参入するスタートアップの増加によっても活性化されています。
世界の遺伝子編集の市場力学
世界の遺伝子編集市場の促進要因
個別化医療への需要の高まり
市場の主な促進要因の1つは、個別化医療に対する需要の高まりです。遺伝子編集技術は、個人の遺伝子構成に基づいてオーダーメイドの治療法を開発する可能性をもたらします。この個別化された医療へのアプローチは、治療結果の改善、副作用の軽減、患者の幸福の向上を約束するものです。個別化医療に対する意識の高まりと標的治療の必要性が、遺伝子編集技術の採用と進歩の大きな促進要因となっています。
世界の遺伝子編集市場における抑制要因
技術に関連する倫理および規制上の課題
市場の主な抑制要因の1つは、この技術に関連する倫理および規制上の課題です。遺伝物質の操作は、特に生殖細胞系列の編集と遺伝子の変化に関して、複雑な倫理上の検討を引き起こします。遺伝子編集の道徳的意味合いと潜在的な長期の帰結をめぐっては、現在も議論が続いています。さらに、遺伝子編集の実践を管理する規制の枠組みは管轄区域によって異なり、絶えず進化しています。包括的な倫理ガイドラインと明確な規制経路の必要性は、市場の成長と広範な採用に向けた大きな抑制要因となっています。
世界の遺伝子編集市場の動向
主な市場の動向の1つは、治療への応用と遺伝子治療の開発への注目の高まりです。遺伝子編集技術は、遺伝性疾患やがんなどの疾患の標的を絞った精密治療に対する新たな可能性を開きました。市場は治療法の研究と臨床応用へのシフトを見せており、アンメットメディカルニーズに対する潜在的なソリューションとして遺伝子編集を模索する企業や研究者が増加しています。この動向は、医療の分野における遺伝子編集の変革の可能性と、疾患の根本的な遺伝的原因に直接対処できる革新的な治療法の追求を反映しています。
当レポートでは、世界の遺伝子編集市場について調査分析し、市場力学と見通し、セグメント分析、企業プロファイルなどを提供しています。
目次
エグゼクティブサマリー
調査手法
親市場の分析
主な市場の考察
- 技術分析
- 価格分析
- サプライチェーン分析
- バリューチェーン分析
- 市場のエコシステム
- IP分析
- 貿易分析
- スタートアップ分析
- 原材料の分析
- イノベーションマトリクス
- パイプライン製品の分析
- マクロ経済指標
- 主な投資の分析
- 主な成功要因
- 競合の程度
市場力学と見通し
- 市場力学
- 促進要因
- 機会
- 抑制要因
- 課題
- 規制情勢
- ポーターの分析
- 将来の混乱についての特別な考察
世界の遺伝子編集市場：タイプ別
- 市場の概要
- CRISPR/Cas9
- TALEN
- ZFN
- 制限酵素、その他
世界の遺伝子編集市場：用途別
- 市場の概要
- 診断
- 創薬、開発
- 細胞株
- 動植物遺伝子工学、その他
世界の遺伝子編集の市場規模：地域別
- 市場の概要
- 北米
- 米国
- カナダ
- 欧州
- ドイツ
- スペイン
- フランス
- 英国
- その他の欧州
- アジア太平洋
- 中国
- インド
- 日本
- 韓国
- その他のアジア太平洋
- ラテンアメリカ
- ブラジル
- その他のラテンアメリカ
- 中東・アフリカ
- GCC諸国
- 南アフリカ
- その他の中東・アフリカ
競合情勢
- 上位5社の比較
- 主要企業の市場ポジショニング（2021年）
- 主な市場企業が採用した戦略
- 主要成功戦略
- 市場における最近の活動
- 主要企業の市場シェア（2021年）
主要企業プロファイル
- Allele Biotech (US)
- GE Healthcare (US)
- Bio-Rad (US)
- CRISPR Therapeutics (Switzerland)
- Merck KGaA (Germany)
- OriGene Technologies (US)
- Precision Biosciences (US)
- Takara Bio (Japan)
- Addgene (US)
- Thermo Fisher Scientific Inc. (US)
- Editas Medicine (US)
- Sangamo Therapeutics (US)
- Lonza Group (Switzerland)
- Horizon Discovery (UK)
- Intellia Therapeutics (US)
- Caribou Biosciences (US)
- Synthego (US)
- GenScript Biotech Corporation (China)
- CRISPR/Cas9 Ltd. (UK)
- Inscripta (US)
Global Gene Editing Market size was valued at USD 3.8 billion in 2021 and is poised to grow from USD 4.06 billion in 022 to USD 6.87 billion by 2030, growing at a CAGR of 6.8% during the forecast period (2023-2030).
The Global Gene Editing Market has experienced significant growth and advancement in recent years, revolutionizing the field of biotechnology and genetic research. Gene editing technologies, such as CRISPR-Cas9, TALENs, and zinc finger nucleases, have emerged as powerful tools for precise modification of DNA sequences in various organisms, including humans. The market is driven by the increasing demand for personalized medicine, advancements in genetic engineering, and rising investments in research and development activities. The therapeutic applications of gene editing, including the treatment of genetic disorders, cancer immunotherapy, and infectious diseases, have gained immense attention, propelling the market growth. Additionally, the agriculture sector has witnessed a surge in the adoption of gene editing techniques to develop crops with improved yield, nutritional value, and resistance to pests and diseases. Global market is characterized by intense competition among key players, including pharmaceutical companies, biotechnology firms, and research institutions. These entities are actively engaged in strategic partnerships, mergers and acquisitions, and collaborations to enhance their research capabilities and expand their product portfolios. North America dominated the global market, driven by the presence of advanced healthcare infrastructure, a strong research base, and substantial investments in genomic research. However, Asia-Pacific is expected to witness significant growth, attributed to the increasing focus on precision medicine, rising healthcare expenditure, and supportive government initiatives in countries like China, Japan, and India. The market is also fueled by supportive government initiatives, collaborations between academic institutions and biotechnology companies, and a growing number of startups entering the gene editing space.
Top-down and bottom-up approaches were used to estimate and validate the size of the global Gene Editing Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined by using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Gene Editing Market Segmental Analysis
The Global Gene Editing Market is segmented by type, application, and region. Based on type, the market can be segmented into CRISPR/Cas9, TALENS, ZFN, restriction enzymes and others. Based on application, the market is segmented into Diagnostics, Drug discovery and development, cell line, animal and plant genetic engineering and others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.
Global Gene Editing Market Dynamics
Drivers of the Global Gene Editing Market
Increasing demand for personalized medicine
One key driver of the gene editing market is the increasing demand for personalized medicine. Gene editing technologies offer the potential to develop tailored therapies and treatments based on an individual's genetic makeup. This personalized approach to medicine holds the promise of improved treatment outcomes, reduced side effects, and enhanced patient well-being. The growing awareness of personalized medicine and the need for targeted therapies have been significant drivers in the adoption and advancement of gene editing technologies.
Restraints in the Global Gene Editing Market
Ethical and regulatory challenges associated with the technology
One key restraint of the gene editing market is the ethical and regulatory challenges associated with the technology. The manipulation of genetic material raises complex ethical considerations, particularly when it comes to germline editing and inheritable genetic changes. There are ongoing debates and discussions surrounding the moral implications and potential long-term consequences of gene editing. Additionally, regulatory frameworks governing gene editing practices vary across different jurisdictions and are continuously evolving. The need for comprehensive ethical guidelines and clear regulatory pathways poses a significant restraint to the gene editing market's growth and widespread adoption.
Market Trends of the Global Gene Editing market
One key market trend in the gene editing market is the increasing focus on therapeutic applications and the development of gene therapies. Gene editing technologies have opened up new possibilities for targeted and precise treatments of genetic disorders, cancers, and other diseases. The market is witnessing a shift towards therapeutic research and clinical applications, with a growing number of companies and researchers exploring gene editing as a potential solution for unmet medical needs. This trend reflects the transformative potential of gene editing in the field of medicine and the pursuit of innovative therapies that can directly address underlying genetic causes of diseases.
Table of Contents
- Executive Summary
- Market Overview
- Wheel of Fortune
- Research Methodology
- Information Procurement
- Secondary & Primary Data Sources
- Market Size Estimation
- Market Assumptions & Limitations
- Parent Market Analysis
- Market Overview
- Market Size
- Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
- Key Market Insights
- Technology Analysis
- Pricing Analysis
- Supply Chain Analysis
- Value Chain Analysis
- Ecosystem of the Market
- IP Analysis
- Trade Analysis
- Startup Analysis
- Raw Material Analysis
- Innovation Matrix
- Pipeline Product Analysis
- Macroeconomic Indicators
- Top Investment Analysis
- Key Success Factor
- Degree of Competition
- Market Dynamics & Outlook
- Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
- Regulatory Landscape
- Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
- Skyquest Special Insights on Future Disruptions
- Political Impact
- Economic Impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact
- Global Gene Editing Market by Type
- Market Overview
- CRISPR/Cas9
- TALENS
- ZFN
- restriction enzymes and others
- Global Gene Editing Market by Application
- Market Overview
- Diagnostics
- Drug discovery and development
- cell line
- animal and plant genetic engineering and others
- Global Gene Editing Market Size by Region
- Market Overview
- North America
- USA
- Canada
- Europe
- Germany
- Spain
- France
- UK
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Latin America
- Brazil
- Rest of Latin America
- Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA
- Competitive Landscape
- Top 5 Player Comparison
- Market Positioning of Key Players, 2021
- Strategies Adopted by Key Market Players
- Top Winning Strategies
- By Development
- By Company
- By Year
- Recent Activities in the Market
- Key Companies Market Share (%), 2021
- Key Company Profiles
- Allele Biotech (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- GE Healthcare (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Bio-Rad (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- CRISPR Therapeutics (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Merck KGaA (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- OriGene Technologies (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Precision Biosciences (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Takara Bio (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Addgene (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Thermo Fisher Scientific Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Editas Medicine (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Sangamo Therapeutics (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Lonza Group (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Horizon Discovery (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Intellia Therapeutics (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Caribou Biosciences (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Synthego (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- GenScript Biotech Corporation (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- CRISPR/Cas9 Ltd. (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Inscripta (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
